181 related articles for article (PubMed ID: 33906076)
1. Tenacissoside G synergistically potentiates inhibitory effects of 5-fluorouracil to human colorectal cancer.
Wang K; Liu W; Xu Q; Gu C; Hu D
Phytomedicine; 2021 Jun; 86():153553. PubMed ID: 33906076
[TBL] [Abstract][Full Text] [Related]
2. Synergistic antitumor effect of 3-bromopyruvate and 5-fluorouracil against human colorectal cancer through cell cycle arrest and induction of apoptosis.
Chong D; Ma L; Liu F; Zhang Z; Zhao S; Huo Q; Zhang P; Zheng H; Liu H
Anticancer Drugs; 2017 Sep; 28(8):831-840. PubMed ID: 28816773
[TBL] [Abstract][Full Text] [Related]
3. Gypenosides Synergistically Enhances the Anti-Tumor Effect of 5-Fluorouracil on Colorectal Cancer In Vitro and In Vivo: A Role for Oxidative Stress-Mediated DNA Damage and p53 Activation.
Kong L; Wang X; Zhang K; Yuan W; Yang Q; Fan J; Wang P; Liu Q
PLoS One; 2015; 10(9):e0137888. PubMed ID: 26368019
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of 5-fluorouracil and oxaliplatin on human colorectal cancer cell survival are synergistically enhanced by sulindac sulfide.
Flis S; Spłwiński J
Anticancer Res; 2009 Jan; 29(1):435-41. PubMed ID: 19331183
[TBL] [Abstract][Full Text] [Related]
5. Curcumin synergizes with 5-fluorouracil by impairing AMPK/ULK1-dependent autophagy, AKT activity and enhancing apoptosis in colon cancer cells with tumor growth inhibition in xenograft mice.
Zhang P; Lai ZL; Chen HF; Zhang M; Wang A; Jia T; Sun WQ; Zhu XM; Chen XF; Zhao Z; Zhang J
J Exp Clin Cancer Res; 2017 Dec; 36(1):190. PubMed ID: 29273065
[TBL] [Abstract][Full Text] [Related]
6. Synergistic enhancement of the antitumor activity of 5-fluorouracil by bornyl acetate in SGC-7901 human gastric cancer cells and the determination of the underlying mechanism of action.
Li J; Wang SX
J BUON; 2016; 21(1):108-17. PubMed ID: 27061538
[TBL] [Abstract][Full Text] [Related]
7. Smad4 sensitizes colorectal cancer to 5-fluorouracil through cell cycle arrest by inhibiting the PI3K/Akt/CDC2/survivin cascade.
Zhang B; Leng C; Wu C; Zhang Z; Dou L; Luo X; Zhang B; Chen X
Oncol Rep; 2016 Mar; 35(3):1807-15. PubMed ID: 26647806
[TBL] [Abstract][Full Text] [Related]
8. Combined 5-FU and ChoKα inhibitors as a new alternative therapy of colorectal cancer: evidence in human tumor-derived cell lines and mouse xenografts.
de la Cueva A; Ramírez de Molina A; Alvarez-Ayerza N; Ramos MA; Cebrián A; Del Pulgar TG; Lacal JC
PLoS One; 2013; 8(6):e64961. PubMed ID: 23762272
[TBL] [Abstract][Full Text] [Related]
9. Synergistic efficacy of 3n-butyrate and 5-fluorouracil in human colorectal cancer xenografts via modulation of DNA synthesis.
Bras-Gonçalves RA; Pocard M; Formento JL; Poirson-Bichat F; De Pinieux G; Pandrea I; Arvelo F; Ronco G; Villa P; Coquelle A; Milano G; Lesuffleur T; Dutrillaux B; Poupon MF
Gastroenterology; 2001 Mar; 120(4):874-88. PubMed ID: 11231942
[TBL] [Abstract][Full Text] [Related]
10. XRCC2-Deficient Cells are Highly Sensitive to 5-Fluorouracil in Colorectal Cancer.
Zhang YZ; An JH; Liu YX; Wu XC; Han SS; Ren XQ; Qin CJ
Cell Physiol Biochem; 2017; 43(3):1207-1219. PubMed ID: 28977800
[TBL] [Abstract][Full Text] [Related]
11. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
[TBL] [Abstract][Full Text] [Related]
12. Curcumin Reverses NNMT-Induced 5-Fluorouracil Resistance via Increasing ROS and Cell Cycle Arrest in Colorectal Cancer Cells.
Li G; Fang S; Shao X; Li Y; Tong Q; Kong B; Chen L; Wang Y; Yang J; Yu H; Xie X; Zhang J
Biomolecules; 2021 Aug; 11(9):. PubMed ID: 34572508
[TBL] [Abstract][Full Text] [Related]
13. Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells.
Wen C; Chen J; Zhang D; Wang H; Che J; Qin Q; He L; Cai Z; Lin M; Lou Q; Huang L; Chen D; Iwamoto A; Ren D; Wang L; Lan P; Wang J; Liu H; Yang X
Cancer Lett; 2016 Dec; 383(2):295-308. PubMed ID: 27713084
[TBL] [Abstract][Full Text] [Related]
14. Esculetin enhances the inhibitory effect of 5-Fluorouracil on the proliferation, migration and epithelial-mesenchymal transition of colorectal cancer.
Yan L; Yu HH; Liu YS; Wang YS; Zhao WH
Cancer Biomark; 2019; 24(2):231-240. PubMed ID: 30689555
[TBL] [Abstract][Full Text] [Related]
15. Anti-Cancer Effects of Zotarolimus Combined with 5-Fluorouracil Treatment in HCT-116 Colorectal Cancer-Bearing BALB/c Nude Mice.
Chang GR; Kuo CY; Tsai MY; Lin WL; Lin TC; Liao HJ; Chen CH; Wang YC
Molecules; 2021 Aug; 26(15):. PubMed ID: 34361836
[TBL] [Abstract][Full Text] [Related]
16. Delivery of Rapamycin by Liposomes Synergistically Enhances the Chemotherapy Effect of 5-Fluorouracil on Colorectal Cancer.
Chen YQ; Zhu WT; Lin CY; Yuan ZW; Li ZH; Yan PK
Int J Nanomedicine; 2021; 16():269-281. PubMed ID: 33469286
[TBL] [Abstract][Full Text] [Related]
17. Methylglyoxal in combination with 5-Fluorouracil elicits improved chemosensitivity in breast cancer through apoptosis and cell cycle inhibition.
Ghosh S; Pal A; Ray M
Biomed Pharmacother; 2019 Jun; 114():108855. PubMed ID: 31003140
[TBL] [Abstract][Full Text] [Related]
18. BET inhibitor bromosporine enhances 5-FU effect in colorectal cancer cells.
Cheng X; Huang Z; Long D; Jin W
Biochem Biophys Res Commun; 2020 Jan; 521(4):840-845. PubMed ID: 31708100
[TBL] [Abstract][Full Text] [Related]
19. PAR2 Inhibition Enhanced the Sensitivity of Colorectal Cancer Cells to 5-FU and Reduced EMT Signaling.
Quan Q; Zhong F; Wang X; Chen K; Guo L
Oncol Res; 2019 Jul; 27(7):779-788. PubMed ID: 30841957
[TBL] [Abstract][Full Text] [Related]
20. Enhanced anti-colorectal cancer effects of carfilzomib combined with CPT-11 via downregulation of nuclear factor-κB in vitro and in vivo.
Tang W; Su G; Li J; Liao J; Chen S; Huang C; Liu F; Chen Q; Ye Y
Int J Oncol; 2014 Sep; 45(3):995-1010. PubMed ID: 24968890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]